Tytuł pozycji:
Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients : founder effect in the Kashubian population
- Tytuł:
-
Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients : founder effect in the Kashubian population
- Autorzy:
-
Jarmoliński, Tomasz
Bałasz-Chmielewska, Irena
Schaefer, Franz
Limon, Janusz
Żurowska, Aleksandra
Drożdż, Dorota
Wasielewska, Anna
Gacka, Ewa
Ksiazek, Joanna
Medynska, Anna
Firszt-Adamczyk, Agnieszka
Borzecka, Halina
Lipska, Beata S.
Tkaczyk, Marcin
Litwin, Mieczysław
Wasielewski, Kacper
Morzuch, Lucyna
Vetter, Dominika
Kuzma-Mroczkowska, Elzbieta
Silska, Magdalena
Szczepańska, Maria
- Data publikacji:
-
2013
- Słowa kluczowe:
-
steroid-resistant nephrotic syndrome
NPHS2
Kashubian population
founder effect
- Język:
-
angielski
- ISBN, ISSN:
-
12341983
- Prawa:
-
Udzielam licencji. Uznanie autorstwa
- Dostawca treści:
-
Repozytorium Uniwersytetu Jagiellońskiego
-
Hereditary nephrotic syndrome is caused by mutations
in a number of different genes, the most common
being NPHS2. The aim of the study was to identify the
spectrum of NPHS2 mutations in Polish patients with the
disease. A total of 141 children with steroid-resistant
nephrotic syndrome (SRNS) were enrolled in the study.
Mutational analysis included the entire coding sequence
and intron boundaries of the NPHS2 gene. Restriction fragment
length polymorphism (RFLP) and TaqMan genotyping
assay were applied to detect selected NPHS2 sequence variants in 575 population-matched controls. Twenty patients
(14 %) had homozygous or compound heterozygous
NPHS2 mutations, the most frequent being c.1032delT
found in 11 children and p.R138Q found in four
patients. Carriers of the c.1032delT allele were exclusively
found in the Pomeranian (Kashubian) region,
suggesting a founder effect origin. The 14 % NPHS2
gene mutation detection rate is similar to that observed
in other populations. The heterogeneity of mutations
detected in the studied group confirms the requirement
of genetic testing the entire NPHS2 coding sequence in
Polish patients, with the exception of Kashubs, who
should be initially screened for the c.1032delT deletion.